Brief Induction Chemoimmunotherapy With Rituximab + Bendamustine + Mitoxantrone Followed by Rituximab in Elderly Patients With Advanced Stage Previously Untreated Follicular Lymphoma
Latest Information Update: 23 May 2023
Price :
$35 *
At a glance
- Drugs Bendamustine (Primary) ; Mitoxantrone (Primary) ; Rituximab (Primary)
- Indications Follicular lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms FLE09
- 29 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Oct 2012 New source identified and integrated (European Clinical Trials Database record: EudraCT2009-012337-29).
- 03 Feb 2012 New trial record